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1. Introduction  
There are numerous toxins and drugs that can cause, in overdose, electrocardiogram (ECG) 
changes, even in patients without history of cardiac pathology. The diagnosis and 
management of patients with an abnormal ECG encountered in a specific toxicity can 
challenge experienced physicians. One must have serious knowledge of basic cardiac 
physiology, in order to understand the ECG changes associated with various drugs and 
toxins.  
The main mechanisms involved include membrane – depressant action (sodium channel 
blockers, slow calcium channel blockers, outward potassium (K+) channel blockers, and 
sodium-potassium adenosine-triphosphatase blockers), and action on autonomic nervous 
system and its sites of cardiovascular action (beta-adrenergic blockers and other 
sympathetic-inhibitors, sympathomimetic, anticholinergic and cholinomimetic substances). 
Many toxins and medications have actions that involve more than one of these mechanisms, 
including hypoxia, electrolyte and metabolic imbalances, and thus may result in a 
combination of electrocardiographic changes. 
In resting state, the myocardial cell membrane is impermeable to positively charged sodium 
ions (Na+). The Na+/K+ ATPase maintains a negative electric potential of approximately 90 
mV in the myocyte. The rapid opening of Na+ channels and massive Na+ influx (phase 0 of 
action potential) explains depolarization of the cardiac cell membrane (fig.1), causing the 
rapid upstroke of the cardiac action potential, which is conducted through the ventricles and 
is expressed as the QRS complex of the ECG. The closure of Na+ channels and the transient 
opening of Ito K+ efflux channels (phase 1) mark the peak of the action potential. Then, phase 
2 of the action potential occurs when the opening of slow calcium (Ca2+) channels produces 
an influx of positive ions with a steady maintenance of the membrane potential and 
myocardial contraction continues. The end of the cardiac cycle is marked by the closure of 
the Ca2+ channels and the activation of the K+ efflux channels, which allow the action 
potential to return to its resting potential of – 90 mV (phase 3). This K+ efflux from the 
myocardial cell is directly responsible for the QT interval on the ECG (Holstege et al., 2006). 
During phase 4 of the cardiac cell action potential, some cardiac fibers allow sodium ions to 
enter the cell, increasing the resting membrane potential, known as spontaneous diastolic 
depolarization. When the threshold in membrane potential is reached, the Na+ channels 
open and another action potential is generated.  
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Fig. 1. Cardiac cycle action potential with corresponding ion changes across the membrane 
and electrocardiographic tracing. Dotted line indicates the changes associated with Na+ 
channel blocker toxicity. Dashed line indicates the changes associated with K+ efflux blocker 
toxicity. Ito= transient outward K+ current; ICa= L-type Ca2+ current; INa= late sodium channel 
current; IKr= rapidly activating delayed-rectifier K+ current; IKs= slowly activating delayed 
rectifier K+ current; IK1= inward rectifier K+ current (adapted from Holstege et al., 2005). 
The atrial and ventricular myocardium contraction, and the conduction in the His-Purkinje 
system depend on sodium entry via the fast sodium channels in phase 0 of the action 
potential, while the conduction in sinoatrial node and atrioventricular (AV) node depend on 
Ca2+ entry during phase 0 via the slow Ca2+ channels (Patel & Benowitz, 2005).  
Cardiac activity is controlled, among other mechanisms, by the autonomic nervous system. 
Sympathetic fibers increase the heart rate, the rate of AV nodal conduction and the 
contracility of the myocardium. The norepinephrine released by postganglionic fibers leads 
to an interaction with beta 1-adrenergic cardiac receptors, and increasing cells’ permeability 
to Na+ and Ca2+, with an increase of contractility, excitability, and conduction. The 
parasympathetic postganglionic fibers innervate the sinus node and AV node. Stimulation 
of muscarinic receptors via releasing of acetylcholine decreases atrial excitability and slows 
the conduction of impulses to the ventricles (Patel & Benowitz, 2005).  
In the setting of drug overdose or of a toxic exposure, ECG abnormalities, especially 
arrhythmias, are produced by direct or indirect sympathomimetic effects, anticholinergic 
effects, the effects of altered central nervous system (CNS) regulation of peripheral 
autonomic system, and myocardial membrane depression. Genesis of arrhythmias in the 
poisoned patient is based on the same three mechanisms as in an ischemic patient: abnormal 
impulse formation, abnormal impulse conduction, and triggered activity. Contributing 
factors to ECG changes are hypotension, hypoxia, acid-base and electrolyte imbalances. 
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2. Membrane – depressant drugs and toxins 
Cardiotoxins are responsible of ECG changes through a combination of membrane 
depressant effects, autonomic disturbances and metabolic changes. The severity of a toxic-
induced conduction block varies depending on the toxin involved and its site of action. 
2.1 Sodium channel blockers 
Inhibition of the fast Na+ channels, in the phase 0 of the action potential (AP), decreases the 
rate of rise and amplitude of the AP in Purkinje fibers, and in atrial and ventricular 
myocardial cells.  As a result, the upslope of depolarization is slowed and the QRS complex 
becomes wide. In a toxicological situation, QRS complex widening likely results directly 
from Na+ channel blockage or indirectly from toxin-induced hyperkalemia (Holstege et al., 
 
Inhibitors of fast Na+ 
channels 
1. Cardiovascular drugs: 
- Type Ia antiarrhythmics (Quinidine, Disopyramide, 
Procainamide) 
- Type Ic antiarrhythmics (Flecainide, Encainide, Propafenone, 
Moricizine) 
- Propranolol and other membrane depressant beta-blockers* 
- Verapamil, Diltiazem 
2. Psychiatric drugs: 
- Carbamazepine 
- Cyclic antidepressants (Amitriptyline, Amoxapine, 
Desipramine, Doxepin, Imipramine, Nortriptyline, 
Maprotiline) 
- Neuroleptics (Thioridazine, Mesoridazine) 
-  Other antidepressants (Citalopram) 
- Antipsychotics (Loxapine) 
3. Other drugs: 
- Amantadine  
- Antihistamines (Diphenhydramine) 
- Chloroquine, Hydroxychloroquine 
- Orphenadrine  
- Narcotic pain relievers (Propoxyphene) 
4. Illicit drugs: Cocaine 
5. Toxins: Quinine, Saxitoxin, Tetrodotoxin 
ECG changes QRS widening 
Right bundle branch pattern 
R wave elevation in aVR lead  
Rightward deviation of QRS axis 
Ventricular tachycardia (VT) and ventricular fibrillation (VF) 
Bradycardia with wide QRS complex  
Asystole  
ST/T changes consistent with ischemia (cocaine toxicity) 
*mechanism not  involving the beta-receptor. 
Table 1. Na+ channel blockers and the resulting ECG changes.  
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2005). Direct toxin-induced blockade of cardiac Na+ channels will cause QRS complex 
widening, and it has been described as a membrane stabilizing effect, a local anesthetic 
effect, or a quinidine-like effect. Some drugs in this category (Table 1) may also affect other 
myocardial ion transfers, such as the Ca2+ influx and K+ efflux (Holstege et al., 2006). Other 
abnormal QRS complex configurations are also possible. In the most severe cases, the QRS 
complex widening becomes so profound that the ultimate origin of the rhythm disturbance 
is impossible (fig. 2). 
 
 
Fig. 2. Na+ channel blocker toxicity (patient with acute Propafenone overdose). Note the 
wide QRS complex, at a rate of 134/min, which suggests, at a first view, monomorphic VT.  
R wave elevation in aVR ≥ 3 mm (fig.3) is the only ECG variable that significantly indicates 
the risk of seizures and arrhythmias in acute tricyclic antidepressant poisoning (Liebelt et 
al., 1995). In addition, QT interval prolongation can occur with tricyclic antidepressant 
poisoning, as well as rightward axis deviation of the terminal 40 msec of the frontal plane 
QRS axis, which is unknown in other Na+ channel blocking agents (Wolfe et al. 1989; 
Berkovitch et al, 1995). Continued prolongation of the QRS complex may result in a sine 
wave pattern and eventual asystole.  
 
 
Fig. 3. Acute poisoning with Amitriptyline. ECG reveals sinus tachycardia 148/min, RBBB 
pattern, QRS complex ≥ 120 ms, as well as R wave elevation in aVR ≥ 3 mm. 
Na+ channel blockers may determine slowed intraventricular conduction, unidirectional 
block, the development of a reentrant circuit, and a resulting VT as well as VF. Because 
many of the Na+ channel blocking agents have also anticholinergic or sympathomimetic 
effects, bradydisrrhythmias are rare. In Na+ channel blocker poisoning by anticholinergic 
and sympathomimetic drugs, the combination of a wide QRS complex and bradycardia is a 
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sign of severe poisoning, indicating that the Na+ channel blockade is so profound that 
tachycardia does not occur, despite the clinical muscarinic antagonism or adrenergic 
agonism (Holstege et al., 2006). Nevertheless, bradycardia may occur because of slowed 
depolarization of pacemaker cells that depend on entry of Na+ ions. 
2.2 Slow Calcium Channel Blockers (CCB)  
All CCBs (Table 2) inhibit the voltage sensitive L-type Ca2+ channel within the cell 
membrane. In the pacemaker cells of the sinoatrial node and AV node, the primary ion 
channel, which controls depolarization, is the slow Ca2+ channel. When inhibited, there is a 
slowing or an inhibition of the specialized tissue to conduct a cardiac impulse (Patel & 
Benowitz, 2005).  
 
Inhibitors of slow 
Ca2+ channels 
1. Dihydropyridines: 
- 1st generation: Nicardipine, Nifedipine 
- 2nd generation: Felodipine, Isradipine, Nimodipine 
- 3rd generation: Amlodipine, Nitrendipine  
- 4th generation: Lercanidipine, Lacidipine  
2. Phenylalkylamine: 
- Verapamil 
- Gallopamil  
3. Benzothiazepine: 
- Diltiazem  
4. Non-selective: 
- Bepridil 
- Mibefradil 
- Fluspirilene 
ECG changes Sinus bradycardia 
Reflex tachycardia (ex. Nifedipine) 
Varying degrees of AV block 
Sinus arrest with AV junctional rhythm 
Asystole  
Wide QRS complex 
ST/T changes  
Table 2. Calcium channel blockers and the resulting ECG changes. 
In CCB toxicity initially occurs a sinus bradycardia, followed by various degrees of AV 
block (fig.4), and junctional and ventricular bradydysrhythmias on ECG. Depending on the 
agent involved, other dysrhythmias may be seen (Gordon, 2006): sinus tachycardia 
(specifically Nifedipine), atrial arrhythmias, and junctional rhythms (fig. 5, 6,7). A wide QRS 
complex may appear, caused by ventricular escape rhythms or by CCB-induced Na+ 
channel blockade which delays of phase 0 of depolarization. Sudden shifts from 
bradydysrhythmias to cardiac arrest have been reported.  
In addition, ECG changes associated with cardiac ischemia (fig.8) may occur as a result of 
the hypotension and changes in the cardiovascular status, especially in patients with pre-
existing cardiac disease (Patel & Benowitz, 2005; Holstege et al., 2006). 
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Fig. 4. Acute poisoning with Verapamil in a 61-years old female. ECG reveals sinus 
bradycardia 41/min, minor right bundle ranch block (RBBB), first-degree AV block (PR 0.32 
sec) and long QT interval (0.64 sec). 
 
 
Fig. 5. Acute poisoning with Norvasc 300 mg in a 31-years old female. ECG reveals sinus 
tachycardia 114/min, signs of ischemia in infero-lateral leads, 14 hours after ingestion 
(systolic blood pressure 70 mmHg). 
 
 
Fig. 6. Same patient, two days after ingestion. ECG reveals accelerated junctional rhythm 
(sinus coronary rhythm, or Zahn rhythm) 114/min, with negative P waves in leads DII, DIII, 
aVF, and disappearance of ischemic changes present at admission. 
 
 
Fig. 7. Acute Diltiazem poisoning at admission. ECG reveals accelerated junctional rhythm 
75/min, retrograde atrial conduction (negative P waves after QRS), and atrial premature beats. 
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Fig. 8. Same patient (Diltiazem poisoning), second day of evolution. ECG reveals atrio-
ventricular dissociation, with escape junctional rhythm and some ventricular captures, and 
signs of ischemia (in inferior and lateral leads). 
2.3 Outward potassium channel blockers 
Medications in the K+ efflux blocker category block the outward flow of K+ from 
intracellular to extracellular spaces. Blockade of the outward K+ currents may prolong the 
cardiac cycle action potential (Fig. 1). The primary electrocardiographic manifestation is QT 
interval prolongation (QTc interval greater than 0.45 seconds in men and 0.47 seconds in 
women). Delay of repolarization causes the myocardial cell to have less charge difference 
across its membrane, and result in the activation of the inward depolarization current (early 
after-depolarization), which is seen on ECG as prominent U waves (Murphy et al., 2007). 
This may promote triggered activity, which potentially can progress to re-entry and 
subsequent polymorphic VT. Toxin-induced blockade of K+ efflux channels during phase 3 
of the action potential corresponding with repolarization and QT interval prolongation may 
place the patient at risk for polymorphic VT or torsades de pointes (Holstege et al., 2005; 
Holstege et al., 2006). The drugs and toxins reported to have this effect are listed in table 3. 
Risk factors for torsades de pointes (TdP) among patients treated with medications that 
prolong QT interval include, among others, female gender, hypokalemia, hypomagnesemia, 
bradycardia, overdose, drug interactions (fig.9), digitalis therapy, and background of the 
patient (preexisting cardiac disease, long QT interval or family history of long QT). (Murphy 
et al., 2007; Roden, 2004) 
 
 
Fig. 9. Drug-induced long QT interval, following interaction between Bisoprolol and 
Amiodarone.  ECG shows long QT interval (0.80 sec), couples of PVB with R/T 
phenomenon preceding a short episode of polymorphic VT. 
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Inhibitors of 
outward K+ 
channel 
1. Cardiovascular drugs:
- Class IA antidysrhythmics**(Disopyramide, Quinidine, Procainamide) 
- Class IC antidysrhythmics (Encainide, Flecainide, Moricizine, 
Propafenone) 
- Class III antidysrhythmics** (e.g. Amiodarone, Dronedarone, Dofetilide, 
Ibutilide, Sotalol, Vernakalant) 
- Anti-anginal/vasodilators*,** (Bepridil, Prenylamine, Terodiline) 
- Antihypertensives (Ketanserin*) 
2. Psychiatric drugs: 
- Antipsychotics (Chlorpromazine, Droperidol, Haloperidol, Mesoridazine, 
Pimozide, Quetiapine, Risperidone, Thioridazine, Ziprasidone) 
- Cyclic antidepressants (Amitriptyline, Amoxapine, Desipramine, 
Doxepin, Imipramine, Nortriptyline, Maprotiline) 
- Other antidepressants (Citalopram, Venlafaxine) 
- Phenothiazines 
3. Other drugs: 
- Antihistamines (Astemizole, Diphenhydramine, Loratidine, 
Terfenadine*, Hydroxyzine) 
- Serotonin 5-HT4 receptor agonist (Cisaprid*,**) 
- Antimicrobials and antimalarics (Ciprofloxacin, Gatifloxacin, 
Levofloxacin, Moxifloxacin, Sparfloxacin, Clarithromycin**, 
Erythromycin**, Pentamidine**, Chloroquine**, Halofantrine, 
Hydroxychloroquine, etc.) 
- Arsenic trioxide 
- Probucol* 
4. Synthetic opioids: Levomethadyl 
5. Opium alkaloids: Papaverine** 
6. Toxins: Quinine, Organophosphates (fig.10) 
ECG changes QT interval prolongation
T- or U-wave abnormalities 
Premature ventricular beats (PVB) followed by TdP 
Sinus tachycardia 
*removed from the market; ** TdP reported. 
Table 3. K+ efflux channel blockers, and the resulting ECG changes. 
 
 
Fig. 10. Acute organophosphate poisoning, five days after ingestion. ECG shows long QT 
interval (0.60 sec), PVB with R/T phenomenon (arrows) preceding a short episode of TdP 
(TORS). 
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Many of these drugs have other effects that can result in significant electrocardiographic 
changes, such as antipsychotics, that can cause muscarinic acetylcholine receptor and alpha-
adrenergic receptor blockade and cardiac cell K+, Na+, and Ca2+ channel blockade (Holstege 
et al., 2006). These effects lead to sinus tachycardia (secondary to anticholinergic effect) or 
reflex tachycardia (secondary to alpha-adrenergic blockade). 
2.4 Sodium–potassium ATPase blockers 
Cardiac glycosides (table 4) inhibit the Na+/K+ adenosine triphosphatase (Na+/K+ATPase) 
pump. As a result, there is an inhibition of the active transport of Na+ and K+ across cell 
membrane, intracellular Na+ increases and the Na+/Ca2+exchanger is secondary activated. 
The intracellular Ca2+ level increases, and augments myofibril activity in cardiac myocytes, 
which results in a positive inotropic effect, and increased automaticity. The cardiac 
glycosides also increase vagal tone that may lead to a direct atrioventricular (AV) nodal 
depression (Holstege et al., 2006). Digitalis derivatives in therapeutic doses are used to 
increase myocardial contractility or slow AV conduction. They modify ECG, changes known 
as ‘‘digitalis effect’’, expressed by abnormal inverted or flattened T waves coupled with ST 
segment depression (most pronounced in leads with tall R waves), QT interval shortening 
(as a result of decreased ventricular repolarization time), PR interval lengthening (increased 
vagal activity), and prominent U-waves. Sagging ST segments, inverted T waves, and 
normal or shortened QT intervals are sometimes identified by their similar appearance to 
“Salvador Dali’s mustache” (Clancy, 2007). These ECG changes are seen with therapeutic 
Digoxin levels and do not represent toxicity (Chung, 1981).  
 
Na+/K+ ATPase 
blockers 
1. Drugs: 
- Digoxin (Lanoxin) 
- Digitoxin 
2. Plants producing cardiac glycosides: 
- Cardenolide type: Strophanthus – ouabain g/k/e-strophanthin, 
Digitalis lanata and Digitalis purpurea (foxglove) – digoxin, digitoxin, 
Nerium oleander (oleander) – oleandrin, Convallaria majalis (Lily of 
the valley), Apocynum cannabinum (Dogbane), Asclepias species. 
- Bufadienolide type: Urginea maritima (Red squill) 
3. Animals producing cardiac glycosides: 
- Bufadienolide type: Bufo marinus toads 
ECG changes - Excitant activity: atrial and junctional premature beats, atrial 
tachycardia, atrial flutter (rare), AF (rare), accelerated junctional 
rhythms, PVB, bigeminy and multifocal, VT, bi-directional VT, VF. 
- Suppressant activity: sinus bradycardia, sinoatrial block, type I 
second degree AV block (Wenckebach), bundle branch blocks, 
complete AV block, type II second degree AV block (rare). 
- Combination of these: atrial tachycardia with AV block, sinus 
bradycardia with junctional tachycardia, Wenckebach with 
junctional premature beats, regularization of ventricular rhythm 
with AF. 
Table 4. Na+/K+ ATPase blocking agents and ECG changes in intoxication (adapted from 
Gordon, 2006; Lapostolle & Borron, 2007). 
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Electrocardiographic abnormalities with cardiac glycoside toxicity are the result of increased 
automaticity (from increased intracellular Ca2+) accompanied by slowed conduction through 
the AV node. In 10% to 15% of cases, ectopic rhythms will be the first sign of intoxication. AV 
block or an increase in ventricular automaticity are the most common manifestations of 
Digoxin toxicity and have been shown to occur in 30%to 40%of verified cases of toxicity. The 
nonspecific dysrhythmias consist of premature ventricular contractions (especially bigeminal 
and multiform), first-, second-, and third degree AV block, sinus bradycardia (fig.11), sinus 
tachycardia, sino-atrial block or arrest, atrial fibrillation (AF) with slow ventricular response 
(fig.12), atrial tachycardia, junctional escape rhythm, AV dissociation, ventricular bigeminy 
and trigeminy, VT (fig.13), TdP, and VF. The more specific dysrhythmias are AF with slow, 
regular ventricular rate (AV dissociation), nonparoxysmal junctional tachycardia (rate 70-130), 
atrial tachycardia with block (atrial rate is usually 150-200), and bi-directional VT. Bi-
directional VT is particularly characteristic of severe toxicity and is the result of alterations of 
intraventricular conduction, junctional tachycardia with aberrant intraventricular conduction, 
or, on rare occasions, alternating ventricular pacemakers. Typically, in the young, slow 
rhythms and conduction defects predominate over ventricular ectopy, which is more 
prominent in older Digoxin-toxic patients. (Litonjua et al., 2005) 
 
 
Fig. 11. Sinus bradicardia 47/min, with ST/T changes, 20 hours after attempted suicide with 
10 mg Digoxin, in an 18 years old man.  
 
 
Fig. 12. AF 56/min, with a pause of 2.96 sec, 15 hours after attempted suicide with Digoxin, 
in a 68 years old woman.  
 
 
Fig. 13. PVB and a short episode of non-sustained VT 135/min, in a 56 years old male with 
Digoxin overdose in attempted suicide.  
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3. Drugs and toxins acting on autonomic nervous system 
In an acute poisoning, ECG changes, especially arrhythmias, can be explained by direct or 
indirect sympathomimetic effects, anticholinergic effects, and the effects of altered central 
nervous system (CNS) regulation of peripheral autonomic activity. Sympathetic fibers 
innervate most parts of the heart. Postganglionic fibers release norepinephrine, which 
interacts with the beta 1- adrenergic cardiac receptors, to increase permeability to Na+ and 
Ca2+, thus leading to increased excitability, conduction and contractility. The vagal 
postganglionic parasympathetic fibers locally release acetylcholine. Vagal stimulation of the 
muscarinic receptors primarily decreases excitability of the atria, and slows the conduction 
of impulse into the ventricles, to a complete blockade of transmission in the AV node, with 
modest direct effects on contractility (Patel & Benowitz, 2005). 
 
Beta-adrenergic 
blockers 
1st generation 
- Oxprenolol (membrane stabilizing effect, intrinsic 
sympathomimetic activity) 
- Propranolol (membrane stabilizing effect) 
- Alprenolol, Nadolol  
- Pindolol (intrinsic sympathomimetic activity) 
- Sotalol (K+ channel blockade) 
- Timolol  
2nd generation 
- Acebutolol (membrane stabilizing effect, intrinsic sympathomimetic 
activity) 
- Practolol, Atenolol, Metoprolol  
- Betaxolol (membrane stabilizing effect, vasodilation secondary to 
calcium channel blocking properties) 
- Bisoprolol  
- Esmolol  
3rd generation 
- Labetalol (vasodilation, alpha-adrenergic antagonist activity) 
- Carvedilol (vasodilation, alpha-adrenergic antagonist activity) 
- Nebivolol (vasodilation by release of nitric oxide) 
- Carteolol (vasodilation by release of nitric oxide) 
- Celiprolol (vasodilation, alpha 2-adrenergic antagonism activity) 
ECG changes Sinus or nodal bradycardia  
AV blocks (first-degree AV block is common) 
Prolonged PR, and QTc intervals 
Prolonged QRS complex (membrane stabilizing agents) 
Ventricular tachydysrhythmias  (membrane stabilizing agents) - fig.14 
Multifocal ventricular extrasystoles, VT, VF (Sotalol) 
Asystole (in severe poisoning) 
Mild tachycardia (Pindolol overdose) 
Table 5. Beta-blockers and ECG changes in intoxication (adapted from Gordon, 2006; 
Holstege et al., 2006; Brubacher, 2007) 
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3.1 Beta-adrenergic blockers (BB) 
BBs competitively inhibit various β-adrenergic receptors, and are listed in table 5.   
They cause in most cases sinus bradycardia. Serious arrhythmias result from purely 
anticholinergic compound poisoning, especially in patients with underlying ischemic heart 
disease (e.g. atrial tachycardia and PVB). In acute BB overdose, the most pronounced effects 
are bradycardia (from decreased sinoatrial node function), varying degrees of AV block, and 
hypotension. Beta-adrenergic antagonists competitively antagonize the effects of 
catecholamines at the beta-adrenergic receptor and blunt the chronotropic and inotropic 
response to catecholamines (Bird, 2007). 
Inhibition of the conducting system most commonly causes first-degree AV block, but 
higher levels of toxicity can promote second- and third-degree AV block (fig.15), junctional 
rhythms, and intraventricular conduction delays (Anderson, 2008). 
Three beta-blockers are known to prolong QTc intervals: Sotalol (fig.16), Propranolol, and 
Acebutolol. Sotalol blocks K+ channels, thereby prolonging the action potential and the 
repolarization duration. The prolongation of the QTc interval predisposes the patient to 
ventricular tachyarrhythmias and TdP, which have been described after both Sotalol 
overdose and therapeutic administration. Propranolol overdose has caused QTc 
prolongation and torsades on rare occasion (Delk et al., 2006). 
 
 
Fig. 14. Acute poisoning 3 hours after ingestion of 2 grams of Propranolol, presenting with 
accelerated idioventricular rhythm 115/min, in a young female. Note the absence of P 
waves, wide QRS complex (0.12 msec). 
 
 
Fig. 15. Acute Metoprolol poisoning presenting with third degree AV block, with narrow 
QRS complex at a rate of 35/min. Atrial activity is represented by P waves, 80/min.  
Beta-adrenergic antagonists also cause myocardial depression, at least in part, by an action 
independent of either catecholamine antagonism or membrane-depressant activity 
(Brubacher, 2007). 
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Fig. 16. Acute Sotalol poisoning presenting with bradyarrhythmias, with severe QT 
prolongation, and monomorphic PVB, R/T phenomenon, and a couple of polymorphic PVB 
(leads V1-V3).   
3.2 Other sympathetic – inhibitors (other than BB) 
Cardiac disturbances caused by sympathetic-inhibiting drugs are listed in table 6.  
 
Sympathetic-inhibiting agents Methyldopa 
Clonidine and other imidazoline derivatives 
Reserpine, Guanethidine 
Prazosin and other alpha-blockers 
ECG changes Sinus, atrial, junctional and ventricular 
bradyarrhythmias 
First degree AV block 
Ventricular tachyarrhythmias 
Table 6. Sympathetic-inhibitors and the resulting ECG changes. 
These drugs are used for their antihypertensive action, explained by central and peripheral 
alpha 2-adrenergic agonist effects. In acute overdose they cause ECG changes, along with 
hypotension, and cardiac failure. Cardiac arrests have been described in adults with 
Clonidine poisoning. Over-the-counter topical decongestants commonly contain 
imidazoline derivatives (naphzoline, tetrahydrozoline, oxymetazoline, and xylometazoline), 
and can cause systemic toxicity after topical exposure, or ingestion, with sympatholytic 
effects, such as bradyarrhythmias and hypotension, related to central alpha 2-adrenergic 
and imidazoline receptor stimulation (Murphy et al., 2007; Wiley II, 2007). 
3.3 Sympathomimetic toxicity 
Sympathetic overactivity can be caused by a number of drugs and toxins (table 7), such as 
illicit drugs, and hydrocarbon solvents, but also by sedative drug withdrawal syndromes. 
The typical ECG changes are sinus and atrial tachycardia, and occasionally ventricular 
dysrrhythmias (in massive exposures). Sinus tachycardia may be the first manifestation of 
exposure to a sympathomimetic. 
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Sympathomimetic 
drugs and toxins 
1. Drugs: 
- Monoamine oxidase inhibitors 
- Phenylpropanolamine and other over-the-counter 
sympathomimetics (decongestants containing phenylephrine, 
pseudoephedrine, ephedrine) 
- Theophylline 
- Ergot alkaloids 
- Beta-adrenoreceptor agonists (Albuterol, Dobutamine, 
Epinephrine, Isoproterenol, Norepinephrine, Ritodrine, 
Terbutaline) 
- Caffeine 
- Chloral hydrate (sedative and hypnotic drug)    
2. Illicit drugs: 
- Amphetamines 
- Cocaine 
- Phencyclidine 
- Delta-tetrahydrocannabinol (cannabis) – fig.17 
- Lysergic acid diethylamide 
- Psilocybin and other hallucinogens 
3. Toxins: 
- Ethanol 
- Hydrocarbon solvents (e.g. toluene, benzene, chloroform, etc.) 
- Freon (and other fluorocarbon aerosols) 
ECG abnormalities Sinus tachycardia  
Sinoatrial slowing with escape junctional or ventricular rhythms 
(solvent inhalation) 
Atrial tachycardia – fig. 18 
Ventricular premature beats 
VT, VF 
Myocardial ischemia or infarction (cocaine, amphetamines, or 
hydrocarbons ingestion) 
Table 7. Sympathomimetic drugs and toxins and the resulting ECG changes. 
 
 
Fig. 17. Paroxysmal supraventricular tachycardia 169/min, in a young female with acute 
cannabis and ethanol poisoning. 
However, other supraventricular or ventricular dysrhythmias may develop if an abnormal 
rhythm is generated in another part of the heart. 
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Fig. 18. Atrial tachycardia 150/min, with variable AV block, in a female with a chronic 
respiratory disease and Theophylline overdosage. 
Either as a result of excessive circulating catecholamines observed with cocaine and 
sympathomimetics, or myocardial sensitization secondary to halogenated hydrocarbons or 
thyroid hormone, or increased second-messenger activity secondary to theophylline, the 
extreme inotropic and chronotropic effects cause dysrhythmias. Altered repolarization, 
increased intracellular Ca2+ concentrations, or myocardial ischemia may cause the 
dysrhythmia. Additionally, cocaine that produce focal myocardial ischemia, can lead to 
malignant ventricular dysrhythmias (Clancy, 2007). In high dose, along with its potent 
sympathomimetic action, cocaine blocks fast Na+ channels in the myocardium, with a 
depression of depolarization, and slowing of conduction velocity, manifested on ECG with 
prolonged PR, QRS, and QT intervals (Murphy et al., 2007). 
3.4 Anticholinergic toxicity 
There are numerous and various anticholinergic drugs and toxins that may be ingested 
(table 8) and produce ECG abnormalities. 
 
Anticholinergic 
drugs and toxins 
1. Drugs: 
- Antihistamines  
- Atropine, scopolamine 
- Tricyclic antidepressants 
- Antipsychotics (e.g. Phenothiazines, Clozapine, Olanzapine) 
2. Toxins: 
- Toxic plants from Solanaceae family containing belladonna 
alkaloids: Belladonna (Atropa belladonna), Henbane 
(Hyoscyamus niger), Jimson Weed (Datura stramonium), 
Mandrake (Mandragora officinarum) 
- Toxic mushrooms: Amanita muscaria 
ECG changes Sinus and atrial tachycardia 
Premature ventricular beats 
Table 8. Drugs and toxins with anticholinergic effect, with induced ECG abnormalities. 
They cause in most cases sinus tachycardia. Serious arrhythmias result from purely 
anticholinergic compound poisoning, especially in patients with underlying ischemic heart 
disease (e.g. atrial tachycardia and ventricular premature beats). Atropine, for example, 
increases myocardial oxygen demand secondary to tachycardia, and can lead to VT and 
fibrillation in patients after myocardial infarction. Patients presenting with anticholinergic 
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toxidrome (mydriasis, diminished bowel sounds, urinary retention, dry mouth, flushed 
skin, tachycardia, and agitation) may have ingested antihistamine-sympathomimetic 
combinations, or tricyclic antidepressants and neuroleptics, having both anticholinergic and 
membrane-depressant effects, which can explain the presence of serious cardiovascular 
disturbances (such as widening of the QRS complex, and a rightward deflection of the 
terminal 40 msec of the QRS complex, with prolongation of the QTc, which creates a 
substrate for the development of TdP). (Murphy et al., 2007; Juurlink, 2007)   
3.5 Cholinomimetic toxicity 
Poisoning by cholinomimetic drugs and toxins (table 9) lead to different ECG aspects. The 
most common type of cholinomimetic toxicity is poisoning with organophosphate and 
carbamate pesticides, resulting in the excessive inhibition of the cholinesterase. The ECG 
changes are unpredictable and often change over the time course of the poisoning.  
 
Cholinomimetic 
drugs and toxins
1. Drugs: 
- Causing acetylcholine release (Alpha 2-adrenergic antagonists, 
Aminopyridines, Carbachol, Guanidine) 
- Direct muscarinic agonists (Pilocarpine, Bethanechol, Methacholine) 
- Direct nicotinic agonists (Carbachol, Succinylcholine) 
- Indirect neuronal nicotinic agonists (Chlorpromazine, local and 
volatile anesthetics, Ketamine) 
- Anticholinesterases (Pyridostigmine, Neostigmine, Physostigmine) 
- Central cholinesterase inhibitors (Rivastigmine, Galantamine, 
Donepezil) 
2. Toxins: 
- Organophosphate and carbamate pesticides 
- Nicotine 
- Muscarine 
- Black widow spider venom 
- Coniine (alkaloid found in poison hemlock and the yellow pitcher 
plant) 
ECG 
abnormalities 
Sinus bradycardia 
Atrial, junctional, or ventricular bradycardia 
AV block 
Sinus tachycardia (seen in early stages of cholinesterase inhibition and 
nicotine poisoning due to ganglionic stimulation) 
VT associated with QT interval prolongation 
Asystole  
Table 9. Cholinomimetic drugs and toxins, and ECG changes induced in acute exposure. 
Early in the course, tachycardia is present, due to acetylcholine stimulation of nicotinic 
receptors, followed by bradycardia, secondary to muscarinic receptor stimulation. In severe 
poisonings, advanced AV block, bradydysrhythmias and asystole may occur (Murphy et al., 
2007). Up to 5 days after exposure, QTc interval prolongation is followed by ventricular 
tachyarrhythmias (fig.19), including TdP (fig.10), due to persistent imbalance between 
sympathetic and parasympathetic influences on the heart, as well as dyselectrolytemias. A 
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rare feature is acute myocardial infarction (fig.20), with a complex mechanism (fig.21) 
explaining its presence (coronary spasm induced by parasympathetic hyperactivity, direct 
toxic effect of pesticide on myocardium). 
 
 
Fig. 19. Acute organophosphate poisoning, five days after exposure. ECG shows QT interval 
prolongation (0.60 sec), short episode of ventricular flutter (FLV), a couple of PVB, and one 
PVB with R on T phenomenon (R/T). 
Patients with clinical signs of cholinesterase inhibition and abnormal ECG (including long 
QT interval) should be monitored continuously, because of the risk of developing 
ventricular arrhythmias (Lionte et al., 2007). Reversible acetylcholinesterase inhibitors, such 
as Donepezil, have a high selectivity for neuronal acetylcholinesterase, and in accidental 
overdose were reported to produce sinus bradycardia (Murphy et al., 2007). 
 
 
 
Fig. 20. Acute organophosphate poisoning, four days after exposure, serum cholinesterase 
normalized with antidote. ECG shows acute ST segment elevation anterior myocardial 
infarction (with increased cardiac enzymes), sinus tachycardia 106/min, QT interval 0.32 
sec.  
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Fig. 21. Cardiac manifestations of organophosphate poisoning and mechanisms involved. 
4. Other substances inducing ECG changes 
4.1 Chemical asphyxiants  
Chemical asphyxiants act in one of two ways. Some prevent the uptake of oxygen in the 
blood. Carbon monoxide interferes with the transport of oxygen to the tissues by strongly 
binding with hemoglobin to form carboxyhemoglobin, which leaves inadequate hemoglobin 
available for oxygen transport. Hydrogen cyanide does not permit the normal oxygen 
transfer either from the blood to the tissues or within the cell itself, resulting in tissue 
hypoxia. Acute exposure to these agents leads to coma and metabolic acidosis, the last 
explaining in part ECG abnormalities (table 10) recorded in such poisoning.   
 
Chemical asphyxiants ECG changes 
Carbon monoxide (CO) T wave flattening or inversion 
ST segment depression or elevation 
Conduction disturbance 
Myocardial infarction (fig.22, 23, 24) 
Arrhythmias occasionally (PVB, atrial fibrillation) 
Hydrogen cyanide  Tachycardia (early) 
Bradicardia, heart block (late) 
Shortening of the ST segment with eventual fusion of the T wave 
into the QRS complex. 
Erratic supraventricular and vntricular arrhythmias 
Ischemic changes 
Asystole  
Zinc phosphide Atrial extrasystoles 
Ventricular arrhythmias 
ST/T changes (fig.25) 
Table 10. Major chemical asphyxiants and their effect on ECG in acute poisoning (adapted 
from Hall, 2007; Murphy et al., 2007; Schraga et al., 2008) 
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Myocardial injury from CO poisoning results from tissue hypoxia, and as damage at the 
cellular level. The affinity of hemoglobin for CO is 200 to 250 times greater than its affinity 
for oxygen. This results in competitive inhibition of oxygen release due to a shift in the 
oxygen-hemoglobin dissociation curve, reduced oxygen delivery, and subsequent tissue 
hypoxia. In CO poisoning, magnitude of ST/T changes doesn’t correlate with the severity of 
the myocardial impairment, other tests, such as echocardiography, being necessary. All 
cardiovascular changes are more prominent in patients with underlying cardiac pathology 
(Murphy et al., 2007; Satran et al., 2005). 
 
 
Fig. 22. ECG in acute CO poisoning, 24 hours after exposure (flattened T wave in DI, 
negative T wave in aVL, ST segment elevation and T wave changes in V1-V3).  
 
 
Fig. 23. ECG in acute CO poisoning, same patient, 52 hours after exposure. Note the 
evolution of ST/T changes in precordial leads. 
 
 
Fig. 24. Same patient, 4 days after exposure. Note the evolution of ST/T changes in 
precordial and lateral leads. 
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In humans, cyanide produces histotoxic hypoxia by combining with the ferric ion in 
mitochondrial cytochrome oxidase, preventing electron transport in the cytochrome system 
and bringing oxidative phosphorylation and ATP production to a halt. The inhibition of 
oxidative metabolism puts increased demands on anaerobic glycolysis, which results in 
lactic acid production and may produce severe acid-base imbalance. Myocardial depression 
with decreased cardiac output produces stagnation hypoxia. Abnormal heartbeat can occur 
in cases of severe poisoning. Bradycardia, intractable low blood pressure, and death may 
result (Hall, 2007). 
 
 
Fig. 25. Attempted suicide with zinc phosphide ingestion in a 19 years old female, 
presenting circulatory collapse and dyspnea. ECG (leads aVR, aVL, aVF, V1-V3) reveals 
tachycardia 160 /min with wide QRS complex, multiple PVC (trigeminy), some with R/T 
phenomenon, and ST/T changes. 
Zinc phosphide is a highly effective insecticide and rodenticide. It is mediated by 
phosphine, which inhibits cytochrome C oxidase. It has been shown recently in nematodes 
that phosphine rapidly perturbs mitochondrial morphology, inhibits oxidative respiration 
by 70%, and causes a severe drop in mitochondrial membrane potential. This failure of 
cellular respiration is likely to be due to a mechanism other than inhibition of cytochrome C 
oxidase. In addition, phosphine and hydrogen peroxide can interact to form the highly 
reactive hydroxyl radical and phosphine also inhibits catalase and peroxidase; both 
mechanisms result in hydroxyl radical associated damage such as lipid peroxidation. The 
major lethal consequence of zinc phosphide ingestion, profound circulatory collapse, is 
secondary to factors including direct effects on cardiac myocytes, fluid loss, and adrenal 
gland damage. There is usually only a short interval between ingestion and the appearance 
of systemic toxicity. Phosphine-induced impairment of myocardial contractility and fluid 
loss leads to circulatory failure, and pulmonary edema. Metabolic acidosis, or mixed 
metabolic acidosis and respiratory alkalosis, are frequent, and contribute to ECG changes 
(Lionte et al., 2004; Proudfoot, 2009).  
4.2 Natural products  
Many natural products and toxins have cardiovascular effects, leading to ECG changes 
(table 11). The clinical and myocardial histological manifestations of scorpion sting resemble 
those of catecholamine infusion. Myocardial infarction has been documented in scorpion 
envenomation with a pathophysiological mechanism involving transient myocardial 
“stunning” (Thomas et al., 2007). 
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Poisonous animals and plants  ECG abnormalities 
Poisonous scorpion stings (venom) Sinus tachycardia, conduction abnormalities, ST/T 
changes with peaked T waves, QT prolongation, atrial 
and ventricular arrhythmias, myocardial infarction 
Black widow spider bites (venom) Tachycardia  
Atrial arrhythmias 
Hymenoptera (bees and wasps) 
stings (venom) 
Tachycardia, dysrhythmias, myocardial infarction 
Ciguatera fish (ciguatoxin) Bradycardia, arrhythmias  
Puffer fish (tetrodotoxin) Bradycardia, arrhythmias 
Scombroid fish (scombrotoxin) Bradycardia, sinus tachycardia, ventricular 
arrhythmias, acute myocardial infarction (fig.26) 
Aconite poisoning (Chinese herbs 
or teas that contain Aconitum 
carmichaelii or A. kusnezoffii) 
Bradycardia 
VT (monomorphic or polymorphic) 
VF 
Table 11. ECG changes induced by natural products poisoning (adapted from Hahn, 2007; 
Lionte, 2010; Murphy et al., 2007; Wandersee, 2006). 
In the pathogenesis of clinical syndrome produced by black widow spider bites was 
suggested to be also involved an excess of catecholamines, while in patients affected by 
Hymenoptera stings, histamine plays a role in pathogenesis.  
Fish-borne poisoning has multiple pathogenic mechanisms, depending on the toxin 
involved. Some of these toxins are heat stable, therefore unaffected by cooking, and gastric 
acid, while others produce the poisoning because of improper fish handling.   
 
 
Fig. 26. Scombroid fish poisoning, 1 hour after ingestion, in a young female, presenting chest 
pain and hypotension (BP 70/45 mmHg). ECG reveals signs of subendocardial myocardial 
infarction (sustained by enzymatic evidence), and sinus tachycardia 139/min.  
Aconite poisoning results from alkaloids contained in teas and herbs, which are not boiled 
enough before ingestion, such as aconitine and mesaconitine (Murphy et al., 2007). 
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Aconitine has Na+ channel-binding properties (maintaining them in an open position), 
which explain, in part, its neurological and cardiovascular toxicity (cardiodepressant 
effects). Vagal stimulation is also involved in pathogenesis of aconitine poisoning. Aconitine 
has a propensity to cause early and delayed after-depolarizations in ventricular myocytes 
that may be due to increased intracellular Ca2+ and Na+. This explains the presence of 
biventricular tachycardia and TdP on ECG (Smolinske et al., 2007).   
4.3 Drugs of abuse 
Some of the most commonly abused drugs are alcohol, nicotine, marijuana, amphetamines, 
cocaine, opium alkaloids and synthetic opioids, gamma-hydroxybutyrate, 3,4-
methylenedioxymethamphetamine (MDMA, ecstasy), and phencyclidine. Drug abuse may 
lead to organ damage, addiction, and disturbed patterns of behavior. Some illicit drugs, 
such as heroin, lysergic acid diethylamide, and phencyclidine hydrochloride, have no 
recognized therapeutic effect in humans. Cardiovascular toxicity of illicit drugs relies on 
multiple pathophysiological mechanisms. Table 12 presents major categories of drugs, and 
the ECG abnormalities reported in acute setting. 
 
Illicit drug ECG  
Amphetamines and 
derivatives 
(including “ecstasy”) 
Sinus tachycardia and supraventricular tachyarrhythmias 
Myocardial ischemia, and infarction 
PVB and ventricular tachydysrhythmias 
Cannabis (marijuana)  Tachycardia (fig. 17) 
Non-specific ST/T changes 
PVC (occasional) and AF 
Cocaine  Sinus bradycardia, complete heart block, bundle branch 
block 
Prolonged QTc, and QRS 
Supraventricular tachyarrhythmias 
VT or fibrillation 
Myocardial infarction 
Gamma-hydroxybutyrate 
(GHB) 
Bradycardia  
Transient P wave inversion in DII, right bundle branch 
block, ST-segment elevation (pediatric) 
U waves (in adults) 
First degree AV block, transient AF (rare) 
Hallucinogens  Tachycardia  
Opiates and opioids Bradycardia (opioids) 
Cardiac conduction abnormalities and dysrhythmias 
(heroin) 
Prolonged QT interval and TdP (methadone) 
QRS prolongation, dysrhythmias (Propoxyphene) 
Tachycardia (Tramadol) 
Table 12. Drugs of abuse and consequent ECG changes in acute poisoning (adapted from 
Albertson, 2004; Albertson et al., 2007, a; Delgado, 2007; Quang, 2007; Traub, 2007; Yip et al., 
2007). 
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Amphetamine and related drugs activate the sympathetic nervous system via central 
nervous system stimulation, peripheral release of catecholamines, inhibition of neuronal 
reuptake of catecholamines, and inhibition of monoamine oxidase. Fenfluramine and 
dexfenfluramine cause serotonin release and block neuronal serotonin uptake. 
Methamphetamine (crank, speed), 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), 
and several other amphetamine derivatives (Lysergic Acid Diethylamide), as well as a 
number of prescription drugs, are used orally and intravenously as illicit stimulants. “Ice” is 
a smokable form of methamphetamine (Albertson, 2004). Direct catecholamine effects, and 
ischemic effects, after coronary vasospasm explain arrhythmias, in amphetamine use. The 
last is involved in the pathogenesis of myocardial infarction after amphetamine use, 
together with direct cardiac toxicity (myocarditis), and thrombus formation (Albertson et al., 
2007, b).  
Most of the hallucinogens are indoleamine or phenylethylamine derivatives, structurally 
similar to the neurotransmitter serotonin. Commonly used hallucinogens include lysergic 
acid diethylamide (LSD), mescaline, 5-methoxy-N,N-diisopropyltriptamine, and psilocybin 
(“magic mushrooms”). They produce a variety of autonomic effects, both parasympathetic 
and sympathetic (Traub, 2007).  
Cocaine is one of the most popular drugs of abuse. Rapidly after smoking or intravenous 
injection (mediated by sympathetic overactivity) appear cardiovascular signs of toxicity. 
Coronary artery spasm and/or thrombosis may result in myocardial infarction, even in 
patients with no coronary disease. Chest pain with electrocardiographic evidence of 
ischemia or infarction in a young, otherwise healthy person suggests cocaine use (Benowitz, 
2004). At low doses, occur sinus bradycardia and ectopic rhythms, based on cocaine’s local 
anesthetic properties and its effects on catecholamines. At high doses, cocaine produces 
direct Na+ and K+ channel blockade (see section 3.3). Enhanced sympathetic stimulation will 
increase intracellular Ca2+ within myocardial cells, and will enhance automaticity, leading to 
afterdepolarizations, and ectopic rhythms (Albertson et al., 2007, a). 
The cannabinoid delta 9-tetrahidrocannabinol (THC) is the principal psychoactive 
constituent of Cannabis sativa (marijuana consists of the leaves and flowering parts of the 
plant). Cardiovascular toxicity is dose-related, and is explained by stimulation of the 
autonomic nervous system, involving both parasympathetic and sympathetic pathways. The 
effects tend to be more serious in patients with preexisting cardiovascular pathology (for 
example, an increased risk of myocardial infarction was reported in the hour following 
marijuana use), but in young, healthy patients, these effects have no serious consequences 
(Delgado, 2007). 
Opiates are a group of naturally occurring compounds derived from the juice of the poppy 
Papaver somniferum. The term opioid refers to these and other derivatives of naturally 
occurring opium (e.g., morphine, heroin, codeine, and hydrocodone) as well as new, totally 
synthetic opiate analogs (e.g., fentanyl, butorphanol, meperidine, methadone, and 
propoxyphene). In general, opioids share the ability to stimulate a number of specific opiate 
receptors in the CNS. With mild or moderate overdose, pulse rate is decreased. 
Cardiotoxicity similar to that seen with tricyclic antidepressants and quinidine can occur in 
patients with severe propoxyphene intoxication. Heroin and propoxyphene toxicity is 
associated with ECG changes, such as non-specific ST/T wave abnormalities, first-degree 
AV block, AF, prolonged QTc intervals, and ventricular dysrhythmias. In the pathogenesis 
of these cardiovascular findings contribute electrolyte, and metabolic derangements, 
hypoxia, or adulterants (e.g. quinine) found in street drugs (Yip et al., 2007). 
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5. Conclusions 
ECG is a valuable source of information in poisoned patients and has the potential to 
enhance and direct their care. Although it seems obvious that an ECG is required following 
exposure to a drug used for cardiovascular indications, many drugs with no overt 
cardiovascular effects from therapeutic dosing become cardiotoxic in overdose. An ECG 
should be examined extremely early in the initial evaluation of most poisoned patients. 
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